TrialX
Image

Combined Laser-surgical Technology of RRD Treatment

Combined Laser-surgical Technology of RRD Treatment

Recruiting
18-60 years
All
Phase N/A

Overview

Purpose: to assess the efficacy and safety of combined laser-surgical technology of RRD treatment

Description

The study takes place in the S.N. Fyodorov "Eye Microsurgery" Federal State Institution located in Moscow, Russian Federation.

The study will include 50 patients with rhegmatogenous retinal detachment due to a horseshoe-tear. In addition to the standard ophthalmological examination, all patients will undergo wide-field optical coherence tomography to determine the extension and localization of the vitreoretinal traction zone. The obtained data will be used to planning the 1st step of laser-surgical treatment. All patients will undergo a combined laser-surgical technology, which includes 3 steps: 1) Nd-YAG laser excision of the vitreoretinal traction zone 2) pneumatic retinopexy (10% C3F8) 3) barrier laser photocoagulation around retinal break after retinal attachment.

The patients are going to be followed up for at least 1 year, the main outcome measures are postoperative primary and final anatomic outcome, BCVA and complications.

Eligibility

Inclusion Criteria:

  1. Rhegmatogenous retinal detachment extending from the 9-o'clock to the 3-o'clock meridians.
  2. Superior retinal break from 9 o'clock to 3 o'clock
  3. Single retinal break not greater than 1 clock hours in size
  4. Physically and mentally co-operated in post-operative head positioning
  5. No (or minimal) proliferative vitreoretinopathy
  6. None or mild vitreous hemorrhage.

Exclusion Criteria:

  1. Severe concomitant eye pathologies (glaucoma, diabetic retinopathy, macular hole, traumas); OR
  2. Ocular media opacities
  3. Previous ocular surgeries
  4. Age <18 years
  5. Previous retinal detachment (index eye)

Study details
    Rhegmatogenous Retinal Detachment

NCT04403750

The S.N. Fyodorov Eye Microsurgery State Institution

5 August 2020

Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.